SCHEMBL5873582

SCHEMBL5873582

O=[N+]([O-])c1ccc2nc(N3CCCCC3)ccc2c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.76
HTR3E A5X5Y0 1/20 0.76
HTR3B O95264 1/20 0.76
CYP1A2 P05177 1/20 0.76
CYP3A4 P08684 1/20 0.76
SLC6A4 P31645 1/20 0.76
CYP2C19 P33261 1/20 0.76
THPO P40225 1/20 0.76
HTR3A P46098 1/20 0.76
HTR3D Q70Z44 1/20 0.76
HTR3C Q8WXA8 1/20 0.76
LMNA P02545 2/20 0.63
NPSR1 Q6W5P4 2/20 0.63
PMP22 Q01453 1/20 0.63
HTR1A P08908 5/20 0.60
MAPT P10636 5/20 0.58
ALOX12 P18054 1/20 0.58
MAPK1 P28482 2/20 0.55
POLB P06746 1/20 0.55
TDP1 Q9NUW8 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31060742 0.87 ALDH1A1 (0.90) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL3559642 0.86 ALDH1A1 (0.72) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
6-Nitroquipazine SCHEMBL401156 0.86 ALDH1A1 (1.00) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL30771682 0.86 ALDH1A1 (0.58) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL6421125 0.86 ALDH1A1 (0.72) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL31373520 0.84 ALDH1A1 (0.69) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL5911024 0.83 ALDH1A1 (0.67) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL6421121 0.82 ALDH1A1 (0.66) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL15521587 0.80 ALDH1A1 (0.63) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4
SCHEMBL3382640 0.78 ALDH1A1 (0.61) ALDH1A1HTR3EHTR3BCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084156-B2 2-Aminoquinoline compounds MERCK & CO., INC. (US) 2006-08-01 US disclosed
US-20050026915-A1 2-Aminoquinoline compounds MERCK SHARP & DOHME CORP. 2005-02-03 US disclosed
EP-1450801-A2 2-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045313-A2 2-AMINOQUINOLINE COMPOUNDS MERCK & CO. INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026915-A1 2-Aminoquinoline compounds MCHR1, MCHR2, MC5R ALDH1A1 460/4885HTR3E 46/4885HTR3B 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.